文献速递慢性肾脏病遗传性与小管间质肾病

转录因子SOX4在肾脏纤维化过程中对肾小管上皮细胞去分化和成纤维细胞活化的关键作用

Critical role of transcription factor SOX4 in tubular epithelial cell dedifferentiation and fibroblast activation during kidney fibrosis.
PubMed 文献 · Kidney Int · 2025-09-24

本研究利用全局、肾小管上皮细胞特异性及成纤维细胞特异性SOX4敲除小鼠,在单侧输尿管梗阻、缺血再灌注损伤或高剂量叶酸诱导的三种临床前肾脏纤维化模型中,探讨SOX4的作用。结果显示SOX4在损伤肾脏中被诱导,其缺失抑制肾小管上皮细胞去分化、成纤维细胞活化并阻碍肾脏纤维化进展;体外实验提示SOX4通过促进TGF-β1-Smad3信号通路发挥作用。

要点

  • SOX4在损伤肾脏中被诱导,其缺失抑制肾小管上皮细胞去分化和成纤维细胞活化。
  • SOX4缺失阻碍单侧输尿管梗阻、缺血再灌注损伤或高剂量叶酸诱导的小鼠肾脏纤维化进展。
  • SOX4通过促进TGF-β1-Smad3信号通路驱动肾小管上皮细胞去分化和成纤维细胞活化。

核心结论

  • SOX4是肾小管上皮细胞去分化和成纤维细胞活化的关键因子,可能成为治疗慢性肾脏病的潜在治疗靶点。

研究设计与样本

  • 研究构建了全局、肾小管上皮细胞特异性及成纤维细胞特异性SOX4敲除小鼠,并采用单侧输尿管梗阻、缺血再灌注损伤或高剂量叶酸诱导的三种临床前肾脏纤维化模型。
  • 体外培养肾小管上皮细胞和成纤维细胞用于确定SOX4的作用及分子机制。

主要发现

  • SOX4在损伤肾脏中被诱导,其缺失抑制肾小管上皮细胞去分化、成纤维细胞活化并阻碍小鼠肾脏纤维化的发展。
  • 体外敲低SOX4可保持上皮表型并抑制转化生长因子-β1诱导的成纤维细胞活化。
  • 机制上,SOX4促进TGF-β1-Smad3信号通路以推动肾小管上皮细胞去分化和成纤维细胞活化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic kidney disease (CKD) is a widely prevalent health issue globally. A striking pathological feature of CKD is kidney fibrosis characterized by excessive production and deposition of extracellular matrix (ECM). Tubular epithelial cell (TEC) dedifferentiation and fibroblast activation contribute to the pathogenesis of kidney fibrosis. However, the molecular mechanisms underlying TEC dedifferentiation and fibroblast activation are not fully understood. Here, we investigated the role of SRY-box transcription factor 4 (SOX4) in regulating TEC dedifferentiation and fibroblast activation during the development of CKD. METHODS: We generated global, TEC-specific, and fibroblast-specific SOX4 knockout mice. These mice were subjected to three preclinical models of kidney fibrosis induced by unilateral ureteral obstruction, ischemia-reperfusion injury, or high-dose folic acid to examine the role of SOX4 in TEC dedifferentiation and fibroblast activation during the development of kidney fibrosis. Cultured TECs and fibroblasts were employed to determine the role and molecular mechanisms of SOX4 in regulating TEC dedifferentiation and fibroblast activation in vitro. RESULTS: SOX4 was induced in the injured kidneys but its deficiency inhibits TEC dedifferentiation, fibroblast activation and further impeded the development of kidney fibrosis in mice. In vitro, knockdown of SOX4 preserved the epithelial phenotype and inhibited fibroblast activation induced by transforming growth factor-β1 (TGF-β1). Mechanistically, SOX4 facilitated the TGF-β1-Smad3 signaling pathway to promote TEC dedifferentiation and fibroblast activation. CONCLUSIONS: Our findings identify SOX4 as a critical factor in TEC dedifferentiation and fibroblast activation suggesting SOX4 may serve as a potential therapeutic target for the treatment of CKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Du H, Jiao B, Xing J, et al. Critical role of transcription factor SOX4 in tubular epithelial cell dedifferentiation and fibroblast activation during kidney fibrosis. Kidney Int. 2025. PMID: 41005570. doi:10.1016/j.kint.2025.08.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。